Monoclonal Antibodies for High-Risk COVID-19 Positive Patients

• Have you tested positive for COVID-19?
• Are you 65 years or older?
• Are you 12 years or older and have a chronic condition?

If so, the IMMEDIATE use of monoclonal antibody treatments could help reduce your need for hospitalization!

What are Monoclonal Antibodies?

The monoclonal antibodies treatments bamlanivimab/etesevimab (made by Eli Lilly and Company) and the therapeutic cocktail casirivimab/imdevimab (made by Regeneron) are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses. Monoclonal antibodies treatments are given to help treat patients with COVID-19. The sooner the treatment, the better!

How do I get treatment?

• Call your local healthcare provider
• Visit a treatment locator at http://infusioncenter.org maintained by the National Infusion Center Association (NICA) or https://protect-hhs.gov/pages/therapeutics-distribution#distribution-locations maintained by the U.S. Department of Health and Human Services (HHS)

Visit your local infusion center.

Click on the link below to view the flyer:

COVID ANTIBODIES INFORMATION